Pharmacy initiative results in 300% increase in inhalers being returned for sustainable disposal Five pharmacies in and around Edinburgh spent ten weeks adding stickers to dispensing bags to encourage patients to return inhalers to the pharmacy.…
More than 20,000 inhalers returned since November 2023 through recycling pilot Exclusive: Since its launch in November 2023, 20,400 inhalers have been returned through the ‘Re-Hale’ scheme, which operates across 78 locations in East Kent.…
NHS rolls out new multiple sclerosis injection that cuts treatment time by 90% The NHS will be one of the first healthcare systems in the world to offer the new injection in the “coming weeks”.…
Joint guidance for asthma recommends replacing SABA with corticosteroid inhalers The draft guidance proposes the use of combined inhaled corticosteroid/formoterol inhalers over previously preferred short-acting beta agonists.…
Greener inhaler propellant is therapeutically equivalent to traditional alternatives, study results suggest Study authors reported overall bioequivalence between inhalers that use HFA-152a as a propellant and traditionally used devices with HFA-134a as a propellant.…
Case-based learning: ensuring safety of oral medicines for children An overview of the risks pharmacists should be aware of regarding oral medicines for children, including how these risks can be appropriately communicated to patients and parents or carers.…
Government and NHS England set up clinical reference group to deal with forthcoming shortage of Pabrinex A medicine supply notification advised NHS trusts to locate and consolidate their current Pabrinex stock, which is likely to be out of stock from August 2024 until September 2025.…
How a pharmacist-led primary care clinic can improve respiratory care Nazir Hussain, a specialist respiratory pharmacist at Dudley Integrated Health and Care NHS Trust, shares how he is improving respiratory care by offering GP-based clinics to help patients manage their COPD and asthma.…
‘World first’ anticancer jab to reduce treatment times by 75%, says NHS England NHS England has announced that it will offer atezolizumab via subcutaneous injection, bringing treatment times down from 30 minutes to as little as 7 minutes.…
Government funding to help UK development of greener inhalers Kindeva Drug Delivery said it is aiming to manufacture inhalers with new propellants that have 90% lower global warming potential than the current greenest option used in the industry.…
